"We can't commit to a specific date, but we're hoping it's going to be very soon, and we've already got patients registering their interest with us now." At the same time, he cautions that the pill will not be available to everyone
The newer anti-obesity medications (AOMs), like the GLP-1 medications indicated for weight loss (i.e., Wegovy and Saxenda ), appear to provide a new hope for many, although they still come with some gastrointestinal side effects
The mean duration of exposure to semaglutide or placebo in the study was 34.2 months
Key takeaways Tesamorelin is a peptide approved to reduce excess abdominal fat in people who have HIV and lipodystrophy
They play a pivotal role in regulating hormones, improving metabolism, and enhancing overall health